Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00382928 · ClinicalTrials.gov registry record · Phase 1

Automatic External Defibrillation Monitoring in Cardiac Arrest

A Phase 1 study of Ventricular Fibrillation and Death, Sudden, Cardiac, sponsored by Foundation for Atlanta Veterans Education and Research.

Completed
Registry status
Phase 1
Development phase
192
Enrollment target
1
Study location

NCT00382928: Completed Phase 1 study of Ventricular Fibrillation and Death, Sudden, Cardiac, sponsored by Foundation for Atlanta Veterans Education and Research.

NCT00382928 is a Phase 1 study of Ventricular Fibrillation and Death, Sudden, Cardiac that has completed, run by Foundation for Atlanta Veterans Education and Research. The registered enrollment target is 192 participants, below the 706-participant average among 7 other Ventricular Fibrillation trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00382928, a Phase 1 study of Ventricular Fibrillation and Death, Sudden, Cardiac, has completed, sponsored by Foundation for Atlanta Veterans Education and Research.

COMPLETED
Registry status
Phase 1
Development phase
192 participants
Enrollment target
1
Study location

Study Summary

We propose to randomize automatic external cardioverter/defibrillators (AECD) in patients who are at high risk for life-threatening abnormal heart rhythms (arrhythmias) and are admitted to the telemetry ward, all other treatments being constant including cardiopulmonary resuscitation. We hypothesize that the automatic, rapid, accurate and specific diagnostic and therapeutic technology used in AECDs will further increase the rate of survival in patients with cardiac arrest through rapid and automatic defibrillation, independent of operator initiation, as compared to standard cardiopulmonary resuscitation initiated by healthcare providers.

Primary Outcome

Time to defibrillation: interval between onset of VT/VF and delivery of first shock. Expected time to defibrillation for AECD group: 30±30 seconds; expected time to defibrillation for Standard of Care group: 180±180.

Interventions

  • DEVICE Defibrillation of pulseless VT/VF by AECD

Study Locations (1)

Georgia

  • Atlanta Veterans Adminstration Medical Center - Decatur

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2006-10
Est. Completion 2009-09
Phase Phase 1

What the finished NCT00382928 record still lists

NCT00382928 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 706-participant average among 7 other Ventricular Fibrillation trials with a reported enrollment target (73% lower).

The record links to 3 conditions, with Ventricular Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Defibrillation of pulseless VT/VF by AECD is the first listed.

NCT00382928 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00382928 about?

NCT00382928 is a clinical study titled "Automatic External Defibrillation Monitoring in Cardiac Arrest". We propose to randomize automatic external cardioverter/defibrillators (AECD) in patients who are at high risk for life-threatening abnormal heart rhythms (arrhythmias) and are admitted to the telemetry ward, all other treatments being constant including cardiopulmonary resuscitation. We hypothesiz...

What is the current status of trial NCT00382928?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 192 participants. The study started on 2006-10. Estimated completion is 2009-09.

What conditions does trial NCT00382928 study?

This clinical trial studies the following conditions: Ventricular Fibrillation, Death, Sudden, Cardiac, Tachycardia, Ventricular.

What interventions are being tested in trial NCT00382928?

The interventions under investigation include: Defibrillation of pulseless VT/VF by AECD (DEVICE).

Who is sponsoring clinical trial NCT00382928?

This trial is sponsored by Foundation for Atlanta Veterans Education and Research, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00382928 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventricular Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00382928, the US trial registry maintained by the National Library of Medicine. NCT00382928 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.